Literature DB >> 17982054

Increased sequence diversity coverage improves detection of HIV-specific T cell responses.

Nicole Frahm1, Daniel E Kaufmann, Karina Yusim, Mark Muldoon, Can Kesmir, Caitlyn H Linde, Will Fischer, Todd M Allen, Bin Li, Ben H McMahon, Kellie L Faircloth, Hannah S Hewitt, Elizabeth W Mackey, Toshiyuki Miura, Ashok Khatri, Steven Wolinsky, Andrew McMichael, Robert K Funkhouser, Bruce D Walker, Christian Brander, Bette T Korber.   

Abstract

The accurate identification of HIV-specific T cell responses is important for determining the relationship between immune response, viral control, and disease progression. HIV-specific immune responses are usually measured using peptide sets based on consensus sequences, which frequently miss responses to regions where test set and infecting virus differ. In this study, we report the design of a peptide test set with significantly increased coverage of HIV sequence diversity by including alternative amino acids at variable positions during the peptide synthesis step. In an IFN-gamma ELISpot assay, these "toggled" peptides detected HIV-specific CD4(+) and CD8(+) T cell responses of significantly higher breadth and magnitude than matched consensus peptides. The observed increases were explained by a closer match of the toggled peptides to the autologous viral sequence. Toggled peptides therefore afford a cost-effective and significantly more complete view of the host immune response to HIV and are directly applicable to other variable pathogens.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982054     DOI: 10.4049/jimmunol.179.10.6638

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  Distinctive features of CD4+ T cell dysfunction in chronic viral infections.

Authors:  Antigoni Morou; Brent E Palmer; Daniel E Kaufmann
Journal:  Curr Opin HIV AIDS       Date:  2014-09       Impact factor: 4.283

2.  Performance of a redesigned HIV Selectest enzyme-linked immunosorbent assay optimized to minimize vaccine-induced seropositivity in HIV vaccine trial participants.

Authors:  Oksana Penezina; Neil X Krueger; Isaac R Rodriguez-Chavez; Michael P Busch; John Hural; Jerome H Kim; Robert J O'Connell; Eric Hunter; Said Aboud; Keith Higgins; Victor Kovalenko; David Clapham; David Crane; Andrew E Levin
Journal:  Clin Vaccine Immunol       Date:  2014-01-08

3.  Cellular immune responses and susceptibility to HIV-1 superinfection: a case-control study.

Authors:  Catherine A Blish; Ozge C Dogan; Walter Jaoko; R Scott McClelland; Kishorchandra Mandaliya; Katherine S Odem-Davis; Barbra A Richardsonb; Julie Overbaugh
Journal:  AIDS       Date:  2012-03-13       Impact factor: 4.177

4.  Exploiting knowledge of immune selection in HIV-1 to detect HIV-specific CD8 T-cell responses.

Authors:  Coral-Ann M Almeida; Steven G Roberts; Rebecca Laird; Elizabeth McKinnon; Imran Ahmad; Niamh M Keane; Abha Chopra; Carl Kadie; David Heckerman; Simon Mallal; Mina John
Journal:  Vaccine       Date:  2010-07-07       Impact factor: 3.641

5.  Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes.

Authors:  Toshiyuki Miura; Mark A Brockman; Chanson J Brumme; Zabrina L Brumme; Jonathan M Carlson; Florencia Pereyra; Alicja Trocha; Marylyn M Addo; Brian L Block; Alissa C Rothchild; Brett M Baker; Theresa Flynn; Arne Schneidewind; Bin Li; Yaoyu E Wang; David Heckerman; Todd M Allen; Bruce D Walker
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

6.  Optimizing peptide matrices for identifying T-cell antigens.

Authors:  Melissa L Precopio; Tiffany R Butterfield; Joseph P Casazza; Susan J Little; Douglas D Richman; Richard A Koup; Mario Roederer
Journal:  Cytometry A       Date:  2008-11       Impact factor: 4.355

7.  HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load.

Authors:  Christine M Rousseau; Marcus G Daniels; Jonathan M Carlson; Carl Kadie; Hayley Crawford; Andrew Prendergast; Philippa Matthews; Rebecca Payne; Morgane Rolland; Dana N Raugi; Brandon S Maust; Gerald H Learn; David C Nickle; Hoosen Coovadia; Thumbi Ndung'u; Nicole Frahm; Christian Brander; Bruce D Walker; Philip J R Goulder; Tanmoy Bhattacharya; David E Heckerman; Bette T Korber; James I Mullins
Journal:  J Virol       Date:  2008-04-23       Impact factor: 5.103

8.  Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1.

Authors:  Yaoyu E Wang; Bin Li; Jonathan M Carlson; Hendrik Streeck; Adrianne D Gladden; Robert Goodman; Arne Schneidewind; Karen A Power; Ildiko Toth; Nicole Frahm; Galit Alter; Christian Brander; Mary Carrington; Bruce D Walker; Marcus Altfeld; David Heckerman; Todd M Allen
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

9.  Design, expression, and processing of epitomized hepatitis C virus-encoded CTL epitopes.

Authors:  Daniel Yerly; David Heckerman; Todd Allen; Todd J Suscovich; Nebojsa Jojic; Carl Kadie; Werner J Pichler; Andreas Cerny; Christian Brander
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

10.  Epitope mapping of HIV-specific CD8+ T cells in a cohort dominated by clade A1 infection.

Authors:  Lyle R McKinnon; Xiaojuan Mao; Joshua Kimani; Charles Wachihi; Christina Semeniuk; Mark Mendoza; Binhua Liang; Ma Luo; Keith R Fowke; Francis A Plummer; T Blake Ball
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.